LIFECORE BIOMEDICAL, INC. Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent
LIFECORE BIOMEDICAL, INC. (LFCR) reported Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent of $1.89 million for the 3-month period ending 2016-08-28, per its 10-Q filed 2016-09-29.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 · last filed 2016-09-29
- LIFECORE BIOMEDICAL, INC. other comprehensive income (loss), tax, portion attributable to parent for the quarter ending 2016-08-28 was $1.89M, a 11.71% increase year-over-year.
- LIFECORE BIOMEDICAL, INC. other comprehensive income (loss), tax, portion attributable to parent for the quarter ending 2016-05-29 was $2.35M.
- LIFECORE BIOMEDICAL, INC. other comprehensive income (loss), tax, portion attributable to parent for the quarter ending 2016-02-28 was -$12.51M, a 638.30% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. other comprehensive income (loss), tax, portion attributable to parent for the quarter ending 2015-11-29 was $1.07M, a 40.11% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. other comprehensive income (loss), tax, portion attributable to parent for fiscal 2016 was -$7.40M, a 195.58% decline from fiscal 2015.
- LIFECORE BIOMEDICAL, INC. other comprehensive income (loss), tax, portion attributable to parent for fiscal 2015 was $7.75M, a 26.81% decline from fiscal 2014.
- LIFECORE BIOMEDICAL, INC. other comprehensive income (loss), tax, portion attributable to parent for fiscal 2014 was $10.58M, a 11.97% increase from fiscal 2013.
- LIFECORE BIOMEDICAL, INC. other comprehensive income (loss), tax, portion attributable to parent for fiscal 2013 was $9.45M.
| Period end | Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2016-08-28 | $1.89M 10-Q · filed 2016-09-29 | $4.24M derived: sum of 2 quarters · filed 2016-09-29 | -$8.28M derived: sum of 3 quarters · filed 2016-09-29 | -$7.21M derived: sum of 4 quarters · filed 2016-09-29 |
| 2016-05-29 | $2.35M derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-01 | -$10.16M derived: sum of 2 quarters · filed 2016-08-01 | -$9.10M derived: sum of 3 quarters · filed 2016-08-01 | -$7.40M 10-K · filed 2016-08-01 |
| 2016-02-28 | -$12.51M 10-Q · filed 2016-03-30 | -$11.44M derived: sum of 2 quarters · filed 2016-03-30 | -$9.75M 10-Q · filed 2016-03-30 | |
| 2015-11-29 | $1.07M 10-Q · filed 2016-01-07 | $2.76M 10-Q · filed 2016-01-07 | ||
| 2015-08-30 | $1.69M 10-Q · filed 2016-09-29 | |||
| 2015-05-31 | $7.75M 10-K · filed 2016-08-01 | |||
| 2015-03-01 | $2.32M 10-Q · filed 2016-03-30 | $4.11M derived: sum of 2 quarters · filed 2016-03-30 | $5.41M 10-Q · filed 2016-03-30 | |
| 2014-11-30 | $1.78M 10-Q · filed 2016-01-07 | $3.09M 10-Q · filed 2016-01-07 | ||
| 2014-08-31 | $1.30M 10-Q · filed 2015-10-01 | |||
| 2014-05-25 | $10.58M 10-K · filed 2016-08-01 | |||
| 2013-05-26 | $9.45M 10-K · filed 2015-07-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |